These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30615506)

  • 1. Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
    Okazaki S; Morimoto T; Kamatani Y; Kamimura T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Washida K; Saito S; Takahashi A; Hirata M; Matsuda K; Mochizuki H; Chong M; Paré G; O'Donnell M; Ago T; Hata J; Ninomiya T; Dichgans M; Debette S; Kubo M; Koizumi A; Ihara M
    Circulation; 2019 Jan; 139(2):295-298. PubMed ID: 30615506
    [No Abstract]   [Full Text] [Related]  

  • 2. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
    PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.
    Kamimura T; Okazaki S; Morimoto T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Yoshimoto T; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Maruyama H; Koizumi A; Ihara M
    Stroke; 2019 Jun; 50(6):1561-1563. PubMed ID: 31060437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the
    Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
    J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed phenotype of
    Zhou H; Jing J; Pu Y; Li W; Meng X; Wang A; Zuo Y; Xu Z; Xu Q; Suo Y; Li H; Wang Y
    Stroke Vasc Neurol; 2023 Dec; 8(6):503-510. PubMed ID: 37137523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.
    Shoemaker LD; Clark MJ; Patwardhan A; Chandratillake G; Garcia S; Chen R; Morgan AA; Leng N; Kirk S; Chen R; Cook DJ; Snyder M; Steinberg GK
    G3 (Bethesda); 2015 Nov; 6(1):41-9. PubMed ID: 26530418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
    Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
    Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
    Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
    Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
    Nomura S; Aihara Y; Akagawa H; Chiba K; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104532. PubMed ID: 31806452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Genotype Frequency of the RNF213 Variant in Patients with Familial Moyamoya Disease in Kyushu, Japan.
    Takamatsu Y; Higashimoto K; Maeda T; Kawashima M; Matsuo M; Abe T; Matsushima T; Soejima H
    Neurol Med Chir (Tokyo); 2017 Nov; 57(11):607-611. PubMed ID: 28931766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
    Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
    PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
    Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
    World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China.
    Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W
    Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.